IFNG and neoplasm: While we did not explore the induction of the IFN program by combinations of EGFR/ERBB inhibitors and IFNγ or TNFα, it is likely that additive or synergistic activation of this pathway occurs and may more fully capture the response to oncogene inhibitors observed in vivo where paracrine interactions between tumor cells and immune cells can occur.